• 전자공학회논문지
• /
• 제54권5호
• /
• pp.133-137
• /
• 2017

본 연구의 목적은 GATE (Geant4 Application for Tomographic Emission) Simulation을 사용하여 치료용 방사성동위원소인 I-131의 감마카메라/SPECT 영상을 획득하여, 실제 기기의 실험결과와 그 특성을 비교 및 분석 하여 GATE simulation의 정확성을 획득하는 것이다. 더 나아가 GATE simulation을 이용한 치료용 방사성동위원소를 위한 감마카메라/SPECT 영상 정량화 기반기술 연구가 가능함을 입증하고자 한다. 본 연구에서 Simulation상에서 구성한 SPECT System은 Stream-R Forte version 1.2 (Philips Medical System, Best and Heerlen, Netherlands)의 설계변수를 참고로 하였다. 감마카메라/SPECT 시스템에서의 I-131 영상특성을 이해하기 위하여 실제 Forte 시스템을 이용하여 산란물질을 사용하였을 때와 사용하지 않았을 때 에너지 스펙트럼 및 선 선원에 대한 선 응답함수 (Line Spread Function, LSF)와 반치폭 (Full Width at Half Maximum, FWHM)을 측정하였다. 또한 실제 실험과의 비교를 위하여 GATE simulation에서 구성한 시스템에서도 동일한 실험 조건 및 변수에 대하여 에너지 스펙트럼 및 선 선원에 대한 LSF 및 FWHM을 측정하였다. 그 결과 산란물질을 사용하지 않았을 때의 에너지 스펙트럼의 경우 실제 실험과 Simulation 모두 364 keV의 위치에서 에너지 피크를 나타내어 동일한 경향의 결과를 보였다. FWHM은 실제 실험과 Simulation 모두에서 선원과 검출기간의 거리가 증가함에 따라 그 크기가 증가하는 경향을 보였으며 오차율은 3.8%로 나타났다. 산란물질을 사용하였을 때의 에너지 스펙트럼 역시 실제 실험과 Simulation 경우 모두에서 비슷한 경향을 나타내었다. 결론적으로, GATE simulation은 치료용 방사성 동위원소에 대해서도 실제 기기의 특성 및 방사성 동위원소의 특징을 모두 반영하고 있으며 이를 이용하여 감마카메라/SPECT에서의 치료용 방사성 동위원소의 정량화에 대한 다양한 연구가 가능 할 것이라고 사료된다.

• 대한방사선기술학회지:방사선기술과학
• /
• 제39권3호
• /
• pp.377-384
• /
• 2016

본 연구는 PET/CT 종사자의 피폭선량 감소 및 방사성의약품의 정확한 방사능량 투여를 목적으로 사용 중인 자동분주기의 분주 최적화에 관한 연구이다. 연구방법은 주사기 종류 및 분주 속도, Vial 압력에 따른 평가 결과를 통해 분주 횟수에 따른 오차 값을 알아보고 보정 값을 적용하여 최적화된 분주방법을 찾고자 하였다. 연구결과 5 ml 주사기에서는 평균 9.38 mCi가 분주되었고, 3 ml에서는 9.55 mCi가 분주되어 3 ml 주사기에서 10 mCi에 근접한 재현성을 보였다. 분주 속도에 따른 평가에서는 속도를 5, 10, 15, 20 mm/min 으로 증가시켜 10회씩 측정한 결과, 5 mm/min의 속도에서 10 mCi 정량에 가까운 방사성의약품이 분주되었다. Needle필터 사용 전/후 Vial 압력에 따른 평가 결과에서는 3 ml 주사기의 경우 사용 전 9.53 mCi, 사용 후 9.84 mCi로 측정되어 Needle필터를 사용한 후 분주하는 것이 최적화된 값으로 확인되었다. 또한 분주 횟수 증가에 따른 보정 값 적용 전/후 방사능 평가에서는 보정 전 9.53 mCi, 보정 후 10.07 mCi로 측정되어 보정 값을 적용한 실험에서 정량 값에 가까운 것으로 확인되었다. 따라서, 방사성의약품 분주 시 최적화된 분주방법은 주사기는 3 ml를 사용하고, 분주 속도는 5 mm/min로 설정하며 분주 시 Needle필터를 사용하고, 장비의 분주 횟수(x)에 따른 보정 값은 [$y=0.097{\times}x$]로 설정하는 것이 좋은 것으로 확인되었다.

• 대한방사성의약품학회지
• /
• 제3권2호
• /
• pp.80-84
• /
• 2017

Re-188 is an excellent and practical radioisotope produced by W-188/Re-188-generator for therapy. We prepared Re-188-tin colloid for therapy of various diseases and tried to treat peritoneal effusion in animal model. Sarcoma-180 cells were injected into ICR mice to induce peritoneal effusion and the mice were grown for 3 d. Re-188-tin colloids (0.25, 0.5, and 1 mCi/mL per 30 g body weight) were injected into the mice and the mice were grown for 90 d. Planar gamma scintigraphy showed even distribution of Re-188-tin colloid radioactivity. Bax expression was found to be dose dependent to Re-188-tin colloid. Normal saline treated group showed the shortest survival time. Among the treated groups, 0.5 mCi dose group showed the longest survival time. In conclusion, Re-188-tin colloid was prepared successfully and showed the feasibility to use as a peritoneal effusion treatment in mice.

• 한국환경보건학회지
• /
• 제40권1호
• /
• pp.55-62
• /
• 2014

Objectives: $^{32}P$-postlabeling assay is the most sensitive method of detecting DNA adduct formation. However, it is limited by a low sample throughput and use of radioisotopes (RI). In this study, we modified it to minimize these limitations and applied it to Z. platypus exposed to Benzo(a)pyrene (BaP) in order to investigate DNA adduct formation (effect biomarker for pollutants) in Z. platypus for assessing risk of waterborne BaP exposure. Methods: DNA hydrolysis was performed only with Micrococcal nuclease (MNase), RI reduction test was performed and the overlapping steps between thin layer chromatography (TLC) and radioisotope high-performance liquid chromatography (RI-HPLC) were omitted. The application of a modified method to Z. platypus exposed to BaP was performed. Results: The results revealed that the amount of RIs used can be reduced roughly 10-fold. Because the analysis time was shortened by 8.5 hours, the sample throughput per hour was increased compared with the previous method. The results of applying modified $^{32}P$-postlabeling assay to Z. platypus, DNA adduct formation in Z. platypus showed dose-dependency with the BaP concentration. Only BPDE-dGMP was detected as a DNA adduct. Conclusion: These results demonstrate that the modified $^{32}P$-postlabeling assay is a suitable method for detecting DNA adduct formation in Z. platypus exposed to waterborne BaP and will be useful in risk assessment of carcinogenic effect in aquatic environment due to BaP.

• 대한핵의학회지
• /
• 제21권1호
• /
• pp.25-32
• /
• 1987

Authors analysed biochemical studies and scintigraphic findings of obstructive jaundice and nonobstructive jaundice in 44 cases of $^{99m}Tc-DISIDA$ scintigraphy with nonvisualization of biliary excretion till 120 min or 240 min after injection of $^{99m}Tc-DISIDA$. Causative diseases of $^{99m}Tc-DISIDA$ scintigraphy with nonvisualization of biliary excretion were in order to choledocholithiasis (25%), hepatitis (25%), cholangiocarcinoma (14%), cholangitis (14%) and pancreas head tumor (11%). In obstructive jaundice, statistically significant findings were elevated alkaline phosphatase above 300 IU/L on biochemical study and single lobe enlargement of the liver, irregular radioisotope uptake of the liver and concave indentation of the gall bladder fossa of the liver on scintigraphy. In nonobstructive jaundice, statistically significant findings were persistent renal excretion of $^{99m}Tc-DISIDA$ and more increased uptake density of the heart than the liver on scintigraphy.

• 한국의학물리학회지:의학물리
• /
• 제32권2호
• /
• pp.25-39
• /
• 2021

Brachytherapy, along with external beam radiation therapy (EBRT), is an essential and effective radiation treatment process. In brachytherapy, in contrast to EBRT, the radiation source is radioisotopes. Because these isotopes can be positioned inside or near the tumor, it is possible to protect other organs around the tumor while delivering an extremely high-dose of treatment to the tumor. Brachytherapy has a long history of more than 100 years. In the early 1900s, the radioisotopes used for brachytherapy were only radium or radon isotopes extracted from nature. Over time, however, various radioisotopes have been artificially produced. As radioisotopes have high radioactivity and miniature size, the application of brachytherapy has expanded to high-dose-rate brachytherapy. Recently, advanced treatment techniques used in EBRT, such as image guidance and intensity modulation techniques, have been applied to brachytherapy. Three-dimensional images, such as ultrasound, computed tomography, magnetic resonance imaging, and positron emission tomography are used for accurate delineation of treatment targets and normal organs. Intensity-modulated brachytherapy is anticipated to be performed in the near future, and it is anticipated that the treatment outcomes of applicable cancers will be greatly improved by this treatment's excellent dose delivery characteristics.

• 대한방사성의약품학회지
• /
• 제8권2호
• /
• pp.139-150
• /
• 2022

Theranostics, a composite word of therapy and diagnosis, is known as personalized medicine and the concept of diagnosis and treatment at the same time. In nuclear medicine, it means performing both therapeutic and diagnostic radioisotope therapy using the same target molecule. The increased production and utilization of ⁶⁴Cu opens a new era of theranostics. The studies introduced here have shown that ⁶⁴CuCl₂ and various compounds or biomolecules labeled with ⁶⁴Cu are unique radiopharmaceuticals with physiological properties suitable for use as diagnostic and therapeutic agents. So far, these two abilities have been described only for radioactive iodine. Although ⁶⁴Cu has complex chemical properties compared to other PET radioisotopes such as ⁶⁸Ga, it has an appropriate half-life and enables high-quality PET images similar to ¹⁸F, which is an advantage in terms of diagnosis. In addition, since it also has therapeutic properties through the release of β^- particles and Auger electrons by electron capture, radiopharmaceuticals using ⁶⁴Cu stand for innovative radiopharmaceuticals for theranostic purposes. Therefore, based on the initial results obtained using ⁶⁴Cu as a therapeutic agent, it is expected that additional research on the application of ⁶⁴Cu will lead to a new era in the theranostics field.

• 대한핵의학회지
• /
• 제16권2호
• /
• pp.1-24
• /
• 1982

Several recent advances in our knowledge of thyroid physiology have broad application to the diagnosis and management of thyroid disorders. For in the thyroid, more than other endocrine organs, pathophysiology can be translated directly into the diagnosis and management of thyroid disease. Graves' disease is a syndrome including goiter with hyperthyroidism, exophthalmos and dermopathy. The pathogenesis of Graves' disease is not yet clearly identified, but various autoantibodies to the thyroid gland and immunopathologic studies indicate that autoimmune processes are involved in the pathogenesis of the disease. The diagnosis and management of Graves' disease are largely dependent on radionuclide techniques as radioimmunoassay, radioactive iodine therapy and so on. Several laboratory tests are also developed to determine the remission of this disase including TRH stimulation test, $T_3$ suppression test and detection of thyroid stimulating immunoglobulins. Autoimmune thyroiditis is almost certainly a primary immunologic disease and the incidence tends to increase recently, mainly due to the application of biopsy technique in thyroid diseases. Thyroid nodules have been a great challenge to physicians because of the possibility of malignancy. But recently, cytologic examination of thyroid aspirate provides a very simple and also reliable diagnostic method in patients with thyroid nodules. In 163 patients with thyroid nodules, only 19.3% was revealed to be malignant. Therefore cytologic examination of thyroid aspirate and thyroid biopsy should be included in the diagnosis of nodular patients prior to surgical intervention. In this paper, a comprehensive review is presented on the pathogenesis, clinical features, laboratory findings and therapeutic modalities of various thyroid diseases on the basis of over 80 researches performed during the past 20 years at radioisotope clinic, Seoul National University Hospital.

• 대한핵의학회지
• /
• 제37권1호
• /
• pp.43-52
• /
• 2003

Microarray technology allows the simultaneous analysis of gene expression patterns of thousands of genes, in a systematic fashion, under a similar set of experimental conditions, thus making the data highly comparable. In some cases arrays are used simply as a primary screen loading to downstream molecular characterization of individual gene candidates. In other cases, the goal of expression profiling is to begin to identify complex regulatory networks underlying developmental processes and disease states. Microarrays were originally used with ceil lines or other simple model systems. More recently, microarrays have been used in the analysis of more complex biological tissues including neural systems and the brain. The application of cDNA arrays in neuropsychiatry has lagged behind other fields for a number of reasons. These include a requirement for a large amount of input probe RNA In fluorescent-glass based array systems and the cellular complexity introduced by multicellular brain and neural tissues. An additional factor that impacts the general use of microarrays in neuropsychiatry is the lack of availability of sequenced clone sets from model systems. While human cDNA clones have been widely available, high qualify rat, mouse, and drosophilae, among others are just becoming widely available. A final factor in the application of cDNA microarrays in neuropsychiatry is cost of commercial arrays. As academic microarray facilitates become more commonplace custom made arrays will become more widely available at a lower cost allowing more widespread applications. in summary, microarray technology is rapidly having an impact on many areas of biomedical research. Radioisotope-nylon based microarrays offer alternatives that may in some cases be more sensitive, flexible, inexpensive, and universal as compared to other array formats, such as fluorescent-glass arrays. In some situations of limited RNA or exotic species, radioactive membrane microarrays may be the most practical experimental approach in studying psychiatric and neurodegenerative disorders, and other complex questions in the brain.

• 방사선산업학회지
• /
• 제3권1호
• /
• pp.25-29
• /
• 2009

Microarrays can be used to screen thousands of binding events in a parallel and high throughput fashion and are of major importance in disease diagnosis and drug discovery. The use of radioisotope is conventionally regarded as one of the most sensitive detection methods. Atherosclerosis is a common disorder affecting arterial blood vessels. It happens when fat, cholesterol, and other substances made in the arterial blood vessels form a hard substances called plaque. Lipoprotein-associated phospholipase $A_2$ ($Lp-PLA_2$), a phospholipase $A_2$ enzyme, is used as a marker for cardiac disease. The detection of $Lp-PLA_2$ was accomplished by using radioactive [$^3H-acetyl$] PAF as a substrate and a feasibility study on RI biochip application to detection of $Lp-PLA_2$, a risk factors of atherosclerosis was performed. Inhibitive activity of a native plant extract was also determined by using the RI biochip. It was found to be applicable to a high-throughput screening of inhibitors for developing atherosclerosis therapeutic agents.